Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for intravenous sedation in pediatric MRI
ChiCTR2500097093Phase 4Completed
- Sponsor
- Lianyungang Maternal and Child Health Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol (2 arms), sponsored by Lianyungang Maternal and Child Health Hospital. Primary endpoint: Rate of Successful Sedation. Started Feb 2025; status: completed.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2500097093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097093.